Yannick Vande Weygaerde

Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection

Jan Van Elslande, Matthijs Oyaert, Scott Ailliet et al. · Journal of Clinical Virology · 2021 · 155 citations · Full text

Viral Persistence, Longitudinal Follow-up, Viral Pathogenesis +4

Prospective longitudinal evaluation of hospitalised COVID-19 survivors 3 and 12 months after discharge

Natalie Lorent, Yannick Vande Weygaerde, Eveline Claeys et al. · ERJ Open Research · 2022 · 109 citations · Full text

Lower persistence of anti-nucleocapsid compared to anti-spike antibodies up to one year after SARS-CoV-2 infection

Jan Van Elslande, Matthijs Oyaert, Natalie Lorent et al. · Diagnostic Microbiology and Infectious Disease · 2022 · 96 citations · Full text

Vaccination, Viral Persistence, Sars-cov-2 Infection +9

Clinical relevance of pulmonary non-tuberculous mycobacterial isolates in three reference centres in Belgium: a multicentre retrospective analysis

Yannick Vande Weygaerde, Nina Cardinaels, Peter Bomans et al. · BMC Infectious Diseases · 2019 · 48 citations · Full text

Loss of GM-CSF-dependent instruction of alveolar macrophages in COVID-19 provides a rationale for inhaled GM-CSF treatment

Cédric Bosteels, Karel Van Damme, Elisabeth De Leeuw et al. · Cell Reports Medicine · 2022 · 43 citations · Full text